- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00762697
Obtaining and Storing Blood Samples and Debridement Samples for Wound Related Research
November 24, 2015 updated by: Randall Wolcott, Southwest Regional Wound Care Center
The intent of this protocol is to obtain blood samples from subjects with or without a wound, so the blood can be used in wound-related scientific studies.
It is also the intent of this protocol to salvage debrided wound material that is normally destined for destruction, so it can be used in wound-related scientific studies.
Study Overview
Status
Completed
Conditions
Detailed Description
The samples will be studied in order to attempt to better understand wounds and their associated barriers to healing.
Analytical methods used to examine the blood or debridement can investigate morphological, molecular, immunological, cellular, viral, biochemical, chemical, genetic, and/or transcriptional components of the samples.
It is the goal of this study to determine if these tests may be able to provide important insights into the keys of wound healing, wound persistence, or wound deterioration.
Study Type
Observational
Enrollment (Actual)
20
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Lubbock, Texas, United States, 79410
- Southwest Regional Wound Care Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Subjects with venous insufficiency, diabetic foot ulcers, decubitus ulcers.
Description
Inclusion Criteria:
Inclusion Criteria for the Collection of Wound Debridement
- The subject must have a full thickness wound.
- The subject must be a candidate for sharp debridement.
- The subject must be 18 years of age or older.
- The subject must be mentally competent as determined by the Investigator Inclusion Criteria for the Collection of Blood
Wounded or Otherwise Not Healthy Subjects, Subjects Weighing Less Than 110 lbs., or Subjects Contributing 50ml of Blood or Less:
- The subject must be 18 years of age or older.
- The subject must be mentally competent as determined by the Investigator.
Not Wounded and Healthy Subjects Weighing at Least 110 lbs. Who May Contribute Up To 500ml of Blood:
- The subject must be 18 years of age or older.
- The subject must be mentally competent as determined by the Investigator.
- The subject must weigh at least 110 lbs.
- The subject must have a hemoglobin level that is in or above the normal range within the last 8 (eight) weeks as determined by standard clinical laboratory testing, the copper sulfate test, or a point of care instrument.
Exclusion Criteria:
Exclusion Criteria for the Collection of Wound Debridement and Blood Collection*
- The subject must not be currently incarcerated or pregnant.
- The subject must not weigh less than 40 lbs.
- If the subject will be contributing more that 50 ml of blood during an 8 (eight) week period, then the subject must not have donated red blood cells within the last 8 (eight) weeks.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2007
Primary Completion (Actual)
April 1, 2012
Study Completion (Actual)
April 1, 2012
Study Registration Dates
First Submitted
September 29, 2008
First Submitted That Met QC Criteria
September 29, 2008
First Posted (Estimate)
September 30, 2008
Study Record Updates
Last Update Posted (Estimate)
November 26, 2015
Last Update Submitted That Met QC Criteria
November 24, 2015
Last Verified
November 1, 2015
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 56-RW-006
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Venous Insufficiency
-
Value Outcomes Ltd.Alfasigma S.p.A.RecruitingChronic Venous Disease | Chronic Insufficiency VenousCzechia
-
State Budgetary Healthcare Institution, National...CompletedEndothelial Dysfunction | Venous Insufficiency of Leg | Venous Insufficiency (Chronic)(Peripheral)Russian Federation
-
GCS Ramsay Santé pour l'Enseignement et la RechercheVivactis M2ResearchRecruitingSuperficial Venous InsufficiencyFrance
-
C. R. BardEnrolling by invitation
-
Medtronic EndovascularCompletedVenous Insufficiency of LegUnited Kingdom, Denmark, Germany, Netherlands
-
Hancock Jaffe Laboratiores, IncSyntactx; AXIOM Real Time MetricsRecruitingDeep Venous Insufficiency (Diagnosis)United States
-
Medtronic EndovascularCompleted
-
TheraclionRecruitingChronic Venous InsufficiencyUnited States, Austria, Czechia
-
Technical University of LisbonFundação para a Ciência e a Tecnologia; Escola Superior de Saúde Dr. Lopes...CompletedChronic Venous InsufficiencyPortugal
-
Angiodynamics, Inc.Completed